OQS
NXTC icon

Occudo Quantitative Strategies’s NextCure NXTC Stock Holding History

Occudo Quantitative Strategies’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,026
Closed -$83K – 1200
2021
Q3 		$83K Sell
1,026
-141
-12% -$12.4K 0.01% 935
2021
Q2 		$112K Sell
1,167
-541
-32% -$55.4K 0.02% 784
2021
Q1 		$205K Sell
1,708
-905
-35% -$131K 0.04% 612
2020
Q4 		$342K Buy
+2,613
New +$338K 0.11% 366

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Occudo Quantitative Strategies's NXTC Position: Q4 2021 in Review

Occudo Quantitative Strategies sold out of NextCure (NXTC) in Q4 2021, closing a stake of 1,026 shares — an estimated $83K sold.

Occudo Quantitative Strategies first reported a position in NXTC in Q4 2020 and held it in 4 quarters. The position peaked at $342K in Q4 2020. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

  • Occudo Quantitative Strategies reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 1,026 NextCure shares in Q4 2021, an estimated $83K.
  • Occudo Quantitative Strategies first reported a position in NextCure in Q4 2020 and held it in 4 quarters.
  • Occudo Quantitative Strategies's NextCure position peaked at $342K in Q4 2020.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.